Anika Therapeutics
Price & Volume
Stats
See more52W Range | $8.67-$22.88 |
Market Cap | $262M |
Shares Short | 367,155 |
Financials
See moreRevenue (12 Mos) | $120.6M |
Revenue Growth (YoY) | 15.6% |
Gross Profit (12 Mos) | $75M |
Diluted EPS | -$0.23 |
News
See moreYahoo Finance • 22 days ago
NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication
Yahoo Finance • 28 days ago
Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study
Yahoo Finance • last month
Roche Gets FDA Priority Tag for Enspryng in Rare Autoimmune Disorder
Yahoo Finance • last month
Novartis' Del-desiran Fails Late-Stage DM1 Study, Shares Fall
About
CEO | Mr. Stephen D. Griffin |
Address | 32 Wiggins Avenue, Bedford, MA, United States, 01730 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 235 |